Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection

被引：0
|
作者：
Karimi-Sari, Hamidreza [1 ]
Rezaee-Zavareh, Mohammad Saeid [1 ]
Falade-Nwulia, Oluwaseun [2 ]
Lim, Joseph K. [3 ]
机构：
[1] Middle East Liver Dis Ctr, Tehran, Iran
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Yale Univ, Sect Digest Dis, Yale Liver Ctr, Sch Med, 333 Cedar St,LMP 1080, New Haven, CT 06520 USA
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷 / 04期
关键词：
Hepatitis C; sofosbuvir; velpatasvir; voxilaprevir; non-responders; SOFOSBUVIR; FAILURE;
D O I：
10.1016/j.jhep.2022.06.024
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1215 / 1217
页数：3
相关论文
共 50 条
  • [1] Sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
    Kilaru, Saikiran M.
    Jacobson, Ira M.
    [J]. FUTURE VIROLOGY, 2019, 14 (02) : 61 - 71
  • [2] Sofosbuvir plus velpatasvir plus voxilaprevir for the treatment of hepatitis C infection
    Cory, Theodore J.
    Mu, Ying
    Gong, Yuqing
    Kodidela, Sunitha
    Kumar, Santosh
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (07) : 749 - 757
  • [3] Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C
    Young-A Heo
    Emma D. Deeks
    [J]. Drugs, 2018, 78 : 577 - 587
  • [4] Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C
    Heo, Young-A
    Deeks, Emma D.
    [J]. DRUGS, 2018, 78 (05) : 577 - 587
  • [5] Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis C
    Voaklander, Rebecca
    Jacobson, Ira M.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (09) : 789 - 795
  • [6] Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C
    Childs-Kean, Lindsey M.
    Brumwell, Natalie A.
    Lodl, Emma F.
    [J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 2259 - 2268
  • [7] Sofosbuvir/Velpatasvir/Voxilaprevir for Previous Treatment Failures With Glecaprevir/Pibrentasvir in Chronic Hepatitis C Infection
    Pearlman, Brian
    Perrys, Michael
    Hinds, Andrew
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (09): : 1550 - 1552
  • [8] SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR IN ADOLESCENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Bansal, Sanjay
    Pawlowska, Malgorzata
    Nebbia, Gabriela
    Di Dato, Fabiola
    Sluzewski, Wojciech
    Giacomet, Vania
    Szenborn, Leszek
    Shao, Jiang
    Yue, Mun Sang
    Hsueh, Chia-Hsiang
    Parhy, Bandita
    Gaggar, Anuj
    Kersey, Kathryn
    Mangia, Alessandra
    Kelly, Deirdre
    Indolfi, Giuseppe
    [J]. HEPATOLOGY, 2020, 72 : 571A - 571A
  • [9] Sofosbuvir-velpatasvir and sofosbuvir-velpatasvir- voxilaprevir: novel treatment options for naive and previously treated hepatitis C infection
    Shin, Hyun Phil
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (04): : 454 - 455
  • [10] Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
    Younossi, Zobair M.
    Stepanova, Maria
    Gordon, Stuart
    Zeuzem, Stefan
    Mann, Michael P.
    Jacobson, Ira
    Bourliere, Marc
    Cooper, Curtis
    Flamm, Steven
    Reddy, K. Rajender
    Kowdley, Kris
    Younossi, Issah
    Hunt, Sharon
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) : 567 - +
12345